Rhumbline Advisers DICERNA PHARMACEUTICALS INC Transaction History

Rhumbline Advisers

$105 Billion
Q2 2024

Shares

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2021 Feb 10, 2022	SELL	N/A	-77,944 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	N/A	-1,119 Reduced 1.42%	77,944 $1.57 Million
Q2 2021 Aug 05, 2021	SELL	N/A	-4,154 Reduced 4.99%	79,063 $2.95 Million
Q1 2021 May 06, 2021	SELL	N/A	-5,614 Reduced 6.32%	83,217 $2.13 Million
Q4 2020 Feb 10, 2021	SELL	N/A	-1,103 Reduced 1.23%	88,831 $1.96 Million
Q3 2020 Nov 12, 2020	SELL	N/A	-12,763 Reduced 12.43%	89,934 $1.62 Million
Q2 2020 Aug 13, 2020	BUY	N/A	25,254 Added 32.61%	102,697 $2.61 Million
Q1 2020 May 06, 2020	BUY	N/A	2,639 Added 3.53%	77,443 $1.42 Million
Q4 2019 Feb 05, 2020	BUY	N/A	2,114 Added 2.91%	74,804 $1.65 Million
Q3 2019 Oct 23, 2019	BUY	N/A	527 Added 0.73%	72,690 $1.04 Million
Q2 2019 Aug 14, 2019	BUY	N/A	2,085 Added 2.98%	72,163 $1.14 Million
Q1 2019 May 01, 2019	BUY	N/A	2,886 Added 4.3%	70,078 $1.03 Million
Q4 2018 Jan 31, 2019	BUY	N/A	26,483 Added 65.05%	67,192 $718,000
Q3 2018 Nov 07, 2018	SELL	N/A	-1,892 Reduced 4.44%	40,709 $621,000
Q2 2018 Aug 06, 2018	BUY	N/A	42,601 New	42,601 $522,000

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.